A61K 2039/6012
Haptens
Official title: {Haptens, e.g. di- or trinitrophenyl (DNP, TNP)}
A61K2039/6012 (Haptens) appears on 59 US grants and 67 published applications in this corpus.
Search patents in A61K- Granted patents
- 59
- Published applications
- 67
- Assignees
- 56
- Inventors
- 162
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 0 |
| 2002 | 3 | 3 |
| 2003 | 0 | 6 |
| 2004 | 0 | 3 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 2 |
| 2008 | 0 | 1 |
| 2009 | 2 | 1 |
| 2010 | 0 | 2 |
| 2011 | 1 | 3 |
| 2012 | 1 | 3 |
| 2013 | 0 | 2 |
| 2014 | 0 | 2 |
| 2015 | 5 | 6 |
| 2016 | 1 | 5 |
| 2017 | 3 | 6 |
| 2018 | 6 | 3 |
| 2019 | 2 | 2 |
| 2020 | 1 | 1 |
| 2021 | 1 | 2 |
| 2022 | 1 | 3 |
| 2023 | 2 | 6 |
| 2024 | 1 | 2 |
| 2025 | 1 | 1 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Vaccines against viral pathogens7 Jul 2026US 12,673,096 B2Hexamer Therapeutics, Inc.
- Bioconjugates and antibodies for immunodetection assisted by derivatization of the mycotoxin patulin27 Jan 2026US 12,534,447 B2Consejo Superior De Investigaciones Cientificas (Csic)
- Antibodies against fentanyl and fentanyl analogs18 Nov 2025US 12,472,248 B2The Government of the United States, as represented by the Secretary of the Army
- Therapeutic compositions and methods with cytokine signaling immunomodulators27 Aug 2024US 12,070,492 B2Hennepin Healthcare Research Institute
- Methods and compositions for substance use disorder vaccine formulations and uses thereof29 Aug 2023US 11,739,054 B2Molecular Express, Inc.
- Micelle comprising amphiphilic peptide, and antigen carrier nanoparticle using same12 Mar 2026US 2026/0069671 A1Rtab Co., Ltd.
- Dual and triple hapten conjugates, compositions, processes for making, and methods of treatment therewith14 Aug 2025US 2025/0255956 A1Purdue Research Foundation
- Bihaptenized autologous vaccines and uses thereof27 Jun 2024US 2024/0207381 A1BioVaxys Inc.
- Nonautologous multi-stressed cancer cells and uses thereof for vaccinating and treating cancers18 Apr 2024US 2024/0123045 A1Brenus Pharma
- Vaccines against viral pathogens2 Nov 2023US 2023/0346920 A1Hexamer Therapeutics, Inc.
Most cited
By later US patents
- Saponin-antigen conjugates and the use thereof99US 5,583,112 ACambridge Biotech Corporation · 1996
- Antigenic modification of polypeptides83US 4,302,386 AThe Ohio State University · 1981
- Antigenic modification of polypeptides80US 4,713,366 AThe Ohio State University Research Foundation · 1987
- Antigenic modification of polypeptides61US 4,201,770 AThe Ohio State University · 1980
- Antigenic modification of polypeptides56US 4,526,716 AThe Ohio State University · 1985